Development of a Collection Kit for Efficient Isolation of SARS-CoV-2 RNA from Urine and Stool Samples
Hussein K. Abdul-Sada, Rasha N. Jawad
Journal of Advances in Microbiology · pp. 180–188 · Published 21 Dec 2024
10.9734/jamb/2024/v24i12882Abstract
Background Information: Consider adding a brief sentence about the significance of detecting SARS-CoV-2 in urine and stool samples. For example, mention how these samples can serve as alternative sources for diagnosis, potentially leading to better patient outcomes. Objective Statement: This study aimed to develop a collection kit for the effective extraction of SARS-CoV-2 RNA from urine and stool samples. The study presents a significant advancement in the field of viral diagnostics by introducing a novel collection kit specifically designed for the extraction of SARS-CoV-2 RNA from urine and stool samples. The demonstrated efficacy of the kit in isolating the virus with high success rates from alternative biological fluids, as well as the superior RNA. Methodology: The kit contains a swab of medical polyester and three tubes, two of them used to inactivate the virus, one contains 3% phenol and the other 1% phenol, and the third tube contains 2 ml of (PBS) Phosphate Buffer Saline added to it 4% of skim milk. Urine or stool samples from Covid-19 patients who reported positive by nasopharyngeal swab during RT-PCR was adde consequently in these three tubes then assessed through RT-PCR testing. Results: The kit succeeded in isolating coronavirus from the urine and stool of patients who reported positive by nasopharyngeal samples. From 20 positive nasopharyngeal samples, there was 18 (90%) of them were positive by using stool sample using this kit, and 15 (75%) of them were give positive result when urine samples were used by this kit. The concentration of RNA of coronavirus which was isolated from urine and feces was higher than in the nasopharyngeal swab during RT-PCR. Mean Ct value of the 20 samples was showed that the mean Ct of nasopharyngeal was 31.5, while urine and stool samples Ct means less concentration of virus. were 25.75 and 24.32 respectively. High The kit was able to serve RNA that was isolated from urine and feces for about 5,10, and 30 days in a percentage of 100%, 94.1%, and 94.1% respectively. Conclusion and Implications: The kit is produce to confirm that the patient is infected with by COVID-19 and to preserve the virus in stool or urine samples of the infected person for a long period until laboratory tests through RT-PCR are conducted on the samples. The kit showed great ability to test SARS-CoV-2, even if it was at low concentrations of virus compared to the examination of nasopharyngeal swabs.
References (16)
- 1 Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study [DOI]
- 2 The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on [DOI]
- 3 Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding [DOI]
- 4 Effect of pH and Ionic Strength on the Spectrophotometric Assessment of Nucleic Acid Purity [DOI]
- 5 Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia [DOI]
- 6 Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea [DOI]
- 7 A modified formula for the preparation of Stuart's Transport Medium.
- 8 RNASwift: A rapid, versatile RNA extraction method free from phenol and chloroform [DOI]
- 9 Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms [DOI]
- 10 NEW TRANSPORT MEDIUM FOR SHIPMENT OF CLINICAL SPECIMENS I [DOI]
- 11 Viral Transport of DNA Damage That Mimics a Stalled Replication Fork [DOI]
- 12 Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study [DOI]
- 13 The effect of the pH of the medium on the antibacterial action of penicillin, streptomycin, chloramphenicol, terramycin, and bacitracin.
- 14 Fecal Collection and Stabilization Methods for Improved Fecal DNA Test for Colorectal Cancer in a Screening Setting [DOI]
- 15 Stability of different viruses in a newly developed transport medium [DOI]
- 16 Purification of RNA by SDS Solubilization and Phenol Extraction [DOI]
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
6
Page views
0
PDF downloads
6
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.